NCT00128011View on ClinicalTrials.gov

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

June 30, 2005

Conditions
Cholera
Interventions
BIOLOGICAL

killed oral cholera vaccine

Trial Locations (1)

10000

National Institute of Hygiene and Epidemiology, Hanoi

All Listed Sponsors
collaborator

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

collaborator

Göteborg University

OTHER

lead

International Vaccine Institute

OTHER

NCT00128011 - Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine | Biotech Hunter | Biotech Hunter